The Patent Finder
MI

Miralogx LLC

First filing 2022
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Nine patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Oct 2041. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2041
Next term end
7
Patent families

When these terms end

Each bar runs from grant to computed term end. 2023 to 2045.
US 12,780,802 Metalloenzyme Inhibitors for Treating Cancers, Alzheimer's Disease, Hemochromatosis, and Other Disorders Oct 16, 2041
US 12,358,892 Metalloenzyme Inhibitors for Treating Cancers, Alzheimer's Disease, Hemochromatosis, and Other Disorders May 3, 2042
US 11,767,329 Antibacterial Compounds, Pharmaceutical Compositions, and Methods of Treating Bacterial Infections Aug 1, 2042
US 11,807,604 Pharmaceutical Compounds, Pharmaceutical Compositions, and Methods of Treating Asthma and Other Disorders Feb 15, 2043
US 12,116,341 Pharmaceutical Compounds, Pharmaceutical Compositions, and Methods of Treating Asthma and Other Disorders Feb 15, 2043
US 12,760,039 Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders no later than Aug 29, 2043
US 12,780,774 Antidepressant Compounds, Pharmaceutical Compositions, and Methods of Treating Depression and Other Disorders Mar 6, 2044
US 12,780,783 Glucose and Lipid Metabolism Regulating Agents, Pharmaceutical Compositions Comprising the Same, and Treatment Methods Mar 21, 2045
US 12,758,527 Antibacterial Compounds, Pharmaceutical Compositions, and Methods of Treating Bacterial Infections Mar 28, 2045
20282033203820432045
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
16 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Pharmaceutical Compounds, Pharmaceutical Compositions, and Methods of Treating Asthma and Other Disorders US 11,807,604
Granted 2023. Computed term ends 2043.
Ends Feb 2043 · High confidence Also notable
Antibacterial Compounds, Pharmaceutical Compositions, and Methods of Treating Bacterial Infections US 11,767,329
Granted 2023. Computed term ends 2042.
Ends Aug 2042 · High confidence Also notable
Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders US 12,760,039
A family of 5 related applications built on the 2026 grant. Too new for citation comparison; protection runs to 2043. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Ends no later than Aug 2043 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 26, 2027
    The maintenance fee for Antibacterial Compounds, Pharmaceutical Compositions, and Methods of Treating Bacterial Infections (US 11,767,329) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
  • 1 fee due May 7, 2027
    The maintenance fee for Pharmaceutical Compounds, Pharmaceutical Compositions, and Methods of Treating Asthma and Other Disorders (US 11,807,604) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 5 of the patents on this record were granted since Aug 16, 2026

What they patent

The 4 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Pharmaceutical Compounds, Pharmaceutical Compositions, and Methods of Treating Asthma and Other Disorders2 in forceto Feb 2043
Metalloenzyme Inhibitors for Treating Cancers, Alzheimer's Disease, Hemochromatosis, and Other Disorders2 in forceto May 2042
Antidepressant Compounds, Pharmaceutical Compositions, and Methods of Treating Depression and Other Disorders1 in forceto Mar 2044
Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders1 in forceto Aug 2043

Patents held now

Soonest term end first.

Showing 1 to 9 of 9

PatentTitleStatusExpiresConfidence
US 12,780,802Metalloenzyme Inhibitors for Treating Cancers, Alzheimer's Disease, Hemochromatosis, and Other Disorders
In force
 · High confidence
In forceHigh confidence
US 12,358,892Metalloenzyme Inhibitors for Treating Cancers, Alzheimer's Disease, Hemochromatosis, and Other Disorders
In force
 · High confidence
In forceHigh confidence
US 11,767,329Antibacterial Compounds, Pharmaceutical Compositions, and Methods of Treating Bacterial Infections
In force
 · High confidence
In forceHigh confidence
US 11,807,604Pharmaceutical Compounds, Pharmaceutical Compositions, and Methods of Treating Asthma and Other Disorders
In force
 · High confidence
In forceHigh confidence
US 12,116,341Pharmaceutical Compounds, Pharmaceutical Compositions, and Methods of Treating Asthma and Other Disorders
In force
 · High confidence
In forceHigh confidence
US 12,760,039Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders
In force
 · Medium confidence
In forceMedium confidence
US 12,780,774Antidepressant Compounds, Pharmaceutical Compositions, and Methods of Treating Depression and Other Disorders
In force
 · Medium confidence
In forceMedium confidence
US 12,780,783Glucose and Lipid Metabolism Regulating Agents, Pharmaceutical Compositions Comprising the Same, and Treatment Methods
In force
 · High confidence
In forceHigh confidence
US 12,758,527Antibacterial Compounds, Pharmaceutical Compositions, and Methods of Treating Bacterial Infections
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 16 applications pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Export every term end as CSV · Pro
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited